Long-term safety and efficacy of methotrexate in patients with palindromic rheumatism
Int J Rheum Dis
.
2022 Dec;25(12):1448-1449.
doi: 10.1111/1756-185X.14420.
Epub 2022 Aug 19.
Authors
Kevin Sheng-Kai Ma
1
2
,
Chien-Te Liu
3
,
Wei-Chiao Kao
3
,
Yung-Heng Lee
4
5
6
Affiliations
1
Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
2
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
3
School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
4
Department of Senior Services Industry Management, Minghsin University of Science and Technology, Hsinchu, Taiwan.
5
Department of Recreation and Sport Management, Shu-Te University, Kaohsiung, Taiwan.
6
Department of Orthopedics, Cishan Hospital, Ministry of Health and Welfare, Kaohsiung, Taiwan.
PMID:
35983921
DOI:
10.1111/1756-185X.14420
No abstract available
Publication types
Letter
Comment
MeSH terms
Arthritis, Rheumatoid* / diagnosis
Arthritis, Rheumatoid* / drug therapy
Humans
Methotrexate / adverse effects
Rheumatic Diseases* / diagnosis
Rheumatic Diseases* / drug therapy
Substances
Methotrexate
Supplementary concepts
Palindromic rheumatism